98%
921
2 minutes
20
Background: The safety and efficacy of herbal medicines including traditional Chinese medicine (TCM) has been one of the major scientific problems in the medical field. In TCM prescriptions, reasonable herbal combinations bring stronger efficacy and low risk of toxicity. However, the rules and mechanisms for herbal combinations are far from complete understood yet.
Purpose: In this study, we investigated the efficacy-toxicity transformation of the licorice-kansui herbal combination under clinical equivalent doses, and study the inside mechanisms.
Study Design: Licorice-kansui or glycyrrhetinic acid-kansuinine A combinations of different combining ratio were given to malignant pleural effusion mice as well as the IEC-6 and S-180 cells.
Methods: The therapeutic and toxic effects were characterized by various indicators; the chemical changes were analyzed by LC-MS method; the role of HS was also studied through its inhibitors.
Results: Low-proportion of licorice combined with kansui exerted comparable therapeutic effects to cisplatin, by reducing pleural effusion, promoting respiration, increasing urine volume, protecting lung tissue, and inhibiting tumor cells by inducing oxidative stress and apoptosis. On the other hand, high-proportion of licorice combined with kansui had poor therapeutic effect but induced oxidative stress, inflammation and tissue damages, especially to the small intestine. This efficacy-toxicity transformation was also reproduced by the glycyrrhetinic acid-kansuinine A combination on IEC-6 epithelial cells and S-180 tumor cells. The transformation was not simply caused by the in-solution solubilization effects of licorice during co-decocted with kansui. Furthermore, the therapeutic and toxic effects were both highly related to the hydrogen sulfide level and its anabolic enzymes, cystathionine-gamma-lyase (CSE) or cystathionine beta-synthase (CBS), either in tissues or in-vitro cells. By inhibiting CSE or CBS, all the therapeutic or toxic effects were abolished both in-vivo and in-vitro. Moreover, the intestinal sulfide-reducing bacteria Desulfovibrio and body drug-metabolism were also important variants influencing the efficacy-toxicity transformation of licorice-kansui herbal combination.
Conclusion: This study comprehensively uncovered the rules of licorice-kansui herbal combination, and for the first time confirmed that HS plays a crucial role in mediating its efficacy-toxicity transformation. Our study not only supports the reasonable clinical usage of these two herbs but also provide ideas and methods for the study of other herb pairs in TCM prescriptions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.phymed.2024.155692 | DOI Listing |
Methods Mol Biol
June 2025
School of Bioengineering & Biosciences, Lovely Professional University, Jalandhar, Punjab, India.
The use of artificial intelligence (AI) in drug discovery has transformed the medical field by substantially shortening up the process of identifying possible medicinal molecules. In-silico validation, which uses computational approaches to predict the efficacy, safety, and mechanisms of action of drug candidates, has become a critical tool in the early phases of drug development. This strategy combines AI algorithms with molecular modeling, docking, and machine learning approaches to mimic drug-target interactions, allowing potential candidates to be identified prior to experimental testing.
View Article and Find Full Text PDFPhytomedicine
January 2025
State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, Shaanxi University of Chin
Background: The safety and efficacy of herbal medicines including traditional Chinese medicine (TCM) has been one of the major scientific problems in the medical field. In TCM prescriptions, reasonable herbal combinations bring stronger efficacy and low risk of toxicity. However, the rules and mechanisms for herbal combinations are far from complete understood yet.
View Article and Find Full Text PDFDrug Metab Dispos
March 2023
Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland (A.M.W., C.D.E., E.P.M., Y.Y., H.N.W., H.K.S., B.C.O., N.N.B.) and Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland (H.K.S.)
Recent advancements in single-cell technologies have enabled detection of RNA, proteins, metabolites, and xenobiotics in individual cells, and the application of these technologies has the potential to transform pharmacological research. Single-cell data has already resulted in the development of human and model species cell atlases, identifying different cell types within a tissue, further facilitating the characterization of tumor heterogeneity, and providing insight into treatment resistance. Research discussed in this review demonstrates that distinct cell populations express drug metabolizing enzymes to different extents, indicating there may be variability in drug metabolism not only between organs, but within tissue types.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
August 2022
Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chines
Hydrogen sulfide is one of the most important signal transduction molecules in the body. Its anabolism and catabolism in the gastrointestinal tract(GT) are extremely high, and its role in the physiological and pathological process of the GT is fairly complicated. The study reviewed recent literature on hydrogen sulfide and GT, and proposed that hydrogen sulfide exerted dual modulating effects in the GT; specifically, it promoted the functions of the GT at low concentrations while damaged the GT at high concentrations.
View Article and Find Full Text PDFBiol Pharm Bull
July 2022
Department of Pharmacy, Shiga University of Medical Science Hospital.
Oral multi-kinase inhibitors have transformed the treatment landscape for various cancer types and provided significant improvements in clinical outcomes. These agents are mainly approved at fixed doses, but the large inter-individual variability in pharmacokinetics and pharmacodynamics (efficacy and safety) has been an unsolved clinical issue. For example, certain patients treated with oral multi-kinase inhibitors at standard doses have severe adverse effects and require dose reduction and discontinuation, yet other patients have a suboptimal response to these drugs.
View Article and Find Full Text PDF